What type of study is this?

This is a Cross-Sectional Study study.

What question did this study set out to answer?

This study aims to explore the financial penalties imposed on pharmaceutical manufacturers due to kickback violations.

March 15, 2026JAMA Network Open0 citationsOpen Access

View Full Paper

Pharmaceutical Manufacturer Kickback Resolutions and Associated Financial Penalties, 2000-2025

TLTobias Liu JRJoseph S. Ross CMChristopher J. Morten

Key Points

This study aims to explore the financial penalties imposed on pharmaceutical manufacturers due to kickback violations.

Abstract

This cross-sectional study investigates the size of financial penalties levied by the US government against pharmaceutical companies accused of violating the Anti-Kickback Statute.

问 AI

Bookmark

View Full Paper

Cite This Study

Liu et al. (Fri,) studied this question.

synapsesocial.com/papers/69b606ea83145bc643d1d788 https://doi.org/https://doi.org/10.1001/jamanetworkopen.2026.1735

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Industry Payments to US Physicians by Specialty and Product Type2024 · 51 citations
2Pharma fines increase, but the pain is not felt on Wall Street2013 · 10 citations
3Industry Payments to Physicians Are Kickbacks. How Should Stakeholders Respond?2022 · 15 citations
4Holding Pharmaceutical and Medical Device Executives Accountable as Responsible Corporate Officers2022 · 16 citations
5Trends in Industry Payments to Physicians in the United States From 2014 to 20182020 · 73 citations

问 AI

Bookmark

View Full Paper